{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA209433"
        ],
        "brand_name": [
          "DEFERASIROX"
        ],
        "generic_name": [
          "DEFERASIROX"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-494",
          "68462-495",
          "68462-496"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DEFERASIROX"
        ],
        "rxcui": [
          "597768",
          "597770",
          "597772"
        ],
        "spl_id": [
          "e2349a09-1e53-462c-b185-225ca0a400a4"
        ],
        "spl_set_id": [
          "59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c"
        ],
        "package_ndc": [
          "68462-494-30",
          "68462-494-90",
          "68462-495-30",
          "68462-495-90",
          "68462-496-30",
          "68462-496-90"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000000144",
          "N0000175522",
          "N0000185506",
          "N0000187062",
          "N0000182138"
        ],
        "pharm_class_moa": [
          "Iron Chelating Activity [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2C8 Inhibitors [MoA]",
          "Cytochrome P450 1A2 Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Iron Chelator [EPC]"
        ],
        "unii": [
          "V8G4MOF2V9"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93219",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide",
      "recall_number": "D-0095-2024",
      "product_description": "Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30",
      "product_quantity": "5,856 bottles",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20231020",
      "center_classification_date": "20231108",
      "report_date": "20231115",
      "code_info": "Lot #: 17220063, Exp 12/2023; 17220396, 17220397, Exp 01/2024; 17220965, Exp 04/2024; 17221187, 17221523, Exp 07/2024; 17221793, 17221794, 17221801, Exp 08/2024",
      "more_code_info": ""
    }
  ]
}